UnitedHealth Group (UNH) Issues FY 2018 Earnings Guidance

UnitedHealth Group (NYSE:UNH) updated its FY 2018 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $12.80-12.80 for the period, compared to the Thomson Reuters consensus estimate of $12.81. The company issued revenue guidance of $226-226 billion, compared to the consensus revenue estimate of $225.6 billion.UnitedHealth Group also updated its FY 2019 guidance to $14.40-14.70 EPS.

Several brokerages have weighed in on UNH. Zacks Investment Research upgraded UnitedHealth Group from a hold rating to a buy rating and set a $292.00 target price on the stock in a research note on Monday. Raymond James lifted their target price on UnitedHealth Group from $285.00 to $304.00 and gave the company a strong-buy rating in a research note on Monday, September 24th. ValuEngine downgraded UnitedHealth Group from a buy rating to a hold rating in a research note on Tuesday, September 11th. Citigroup downgraded UnitedHealth Group from a buy rating to a neutral rating and set a $288.00 target price on the stock. in a research note on Monday, September 10th. Finally, Piper Jaffray Companies lifted their target price on UnitedHealth Group to $300.00 and gave the company an overweight rating in a research note on Wednesday, October 17th. One analyst has rated the stock with a hold rating, twenty-two have assigned a buy rating and one has given a strong buy rating to the stock. UnitedHealth Group presently has an average rating of Buy and an average price target of $289.55.

Shares of UNH traded up $4.54 during mid-day trading on Monday, hitting $266.16. The company’s stock had a trading volume of 3,625,246 shares, compared to its average volume of 3,156,807. The company has a debt-to-equity ratio of 0.61, a current ratio of 0.69 and a quick ratio of 0.69. The stock has a market capitalization of $251.69 billion, a P/E ratio of 26.43, a P/E/G ratio of 1.51 and a beta of 0.78. UnitedHealth Group has a 1-year low of $208.48 and a 1-year high of $278.00.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, October 16th. The healthcare conglomerate reported $3.41 EPS for the quarter, beating the consensus estimate of $3.30 by $0.11. The business had revenue of $56.56 billion during the quarter, compared to analysts’ expectations of $56.34 billion. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The company’s quarterly revenue was up 12.4% compared to the same quarter last year. During the same period last year, the firm earned $2.66 EPS. Research analysts anticipate that UnitedHealth Group will post 12.81 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 13th. Stockholders of record on Monday, December 3rd will be issued a $0.90 dividend. The ex-dividend date is Friday, November 30th. This represents a $3.60 annualized dividend and a dividend yield of 1.35%. UnitedHealth Group’s dividend payout ratio is currently 35.75%.

In other news, CEO Steven H. Nelson sold 26,033 shares of the firm’s stock in a transaction that occurred on Friday, September 7th. The stock was sold at an average price of $270.65, for a total value of $7,045,831.45. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, Director Richard T. Burke sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 12th. The shares were sold at an average price of $263.41, for a total value of $5,268,200.00. Following the completion of the sale, the director now directly owns 1,720,112 shares of the company’s stock, valued at $453,094,701.92. The disclosure for this sale can be found here. Insiders sold a total of 54,338 shares of company stock valued at $14,516,459 over the last three months. Insiders own 0.87% of the company’s stock.

An institutional investor recently raised its position in UnitedHealth Group stock. Argent Trust Co increased its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 8.3% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 13,911 shares of the healthcare conglomerate’s stock after purchasing an additional 1,061 shares during the quarter. UnitedHealth Group accounts for 0.8% of Argent Trust Co’s investment portfolio, making the stock its 15th biggest holding. Argent Trust Co’s holdings in UnitedHealth Group were worth $3,066,000 at the end of the most recent quarter. Hedge funds and other institutional investors own 85.45% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was first posted by WKRB News and is the property of of WKRB News. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://www.wkrb13.com/2018/11/26/unitedhealth-group-unh-issues-fy-2018-earnings-guidance.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: How to calculate the annual rate of depreciation

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply